Antiarrhythmic Drugs: Class II Agents as nb-Adrenergic Blockers.
Gardado en:
| Formato: | Article de revue numérique |
|---|---|
| Idioma: | Indéterminée |
| Publicado: |
Journal of Visualized Experiments (JoVE)
2023.
|
| Acceso en liña: | Accès Université d'Orléans |
| Nota: |
JOVE Education |
| Variante du titre: | Antiarrhythmic Drugs: Class II Agents as nb-Adrenergic Blockers |
Títulos similares
-
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers.
(Article de revue numérique)
Journal of Visualized Experiments (JoVE), 2023 -
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers.
(Article de revue numérique)
Journal of Visualized Experiments (JoVE), 2023 -
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers.
(Article de revue numérique)
Journal of Visualized Experiments (JoVE), 2023 -
Adrenergic Antagonists: Chemistry and Classification of nb-Receptor Blockers.
(Article de revue numérique)
Journal of Visualized Experiments (JoVE), 2023 -
Adrenergic Antagonists: <U+0251> and nb-Receptor Blockers.
(Article de revue numérique)
Journal of Visualized Experiments (JoVE), 2023